🚧 ꡬ좕 쀑 β€” 데이터가 λΆ€μ •ν™•ν•  수 μžˆμŠ΅λ‹ˆλ‹€. 더 λ§Žμ€ κΈ°μ—…κ³Ό μ§€ν‘œλ₯Ό μΆ”κ°€ν•˜κ³  μžˆμŠ΅λ‹ˆλ‹€.

Republic Services, Inc. vs Regeneron Pharmaceuticals, Inc.

μ‹œκ°„μ— λ”°λ₯Έ μ‹œκ°€μ΄μ•‘ 비ꡐ

Republic Services, Inc.

$66.9B

μˆœμœ„ #240

Regeneron Pharmaceuticals, Inc.

$68.6B

μˆœμœ„ #236

μ‹œκ°„μ— λ”°λ₯Έ μ‹œκ°€μ΄μ•‘

μ£Όμš” μˆœκ°„

  • Regeneron Pharmaceuticals, Inc.이(κ°€) 2000λ…„κΉŒμ§€ Republic Services, Inc.을(λ₯Ό) μΆ”μ›”ν–ˆμŠ΅λ‹ˆλ‹€
  • Republic Services, Inc.이(κ°€) 2002λ…„κΉŒμ§€ Regeneron Pharmaceuticals, Inc.을(λ₯Ό) μΆ”μ›”ν–ˆμŠ΅λ‹ˆλ‹€
  • Regeneron Pharmaceuticals, Inc.이(κ°€) 2012λ…„κΉŒμ§€ Republic Services, Inc.을(λ₯Ό) μΆ”μ›”ν–ˆμŠ΅λ‹ˆλ‹€

연도별 비ꡐ

연도Republic Services, Inc.Regeneron Pharmaceuticals, Inc.선두
2026$66.9B$68.6BRegeneron Pharmaceuticals, Inc.
2025$64.8B$79.3BRegeneron Pharmaceuticals, Inc.
2024$60.9B$72.8BRegeneron Pharmaceuticals, Inc.
2023$49.3B$89.7BRegeneron Pharmaceuticals, Inc.
2022$38.0B$73.7BRegeneron Pharmaceuticals, Inc.
2021$40.6B$64.5BRegeneron Pharmaceuticals, Inc.
2020$27.6B$49.4BRegeneron Pharmaceuticals, Inc.
2019$25.2B$38.4BRegeneron Pharmaceuticals, Inc.
2018$19.9B$38.2BRegeneron Pharmaceuticals, Inc.
2017$18.2B$38.4BRegeneron Pharmaceuticals, Inc.
2016$15.1B$37.5BRegeneron Pharmaceuticals, Inc.
2015$11.3B$55.5BRegeneron Pharmaceuticals, Inc.
2014$10.1B$41.9BRegeneron Pharmaceuticals, Inc.
2013$8.1B$28.1BRegeneron Pharmaceuticals, Inc.
2012$6.9B$17.5BRegeneron Pharmaceuticals, Inc.
2011$6.3B$5.7BRepublic Services, Inc.
2010$6.6B$3.4BRepublic Services, Inc.
2009$6.1B$2.5BRepublic Services, Inc.
2008$5.2B$1.9BRepublic Services, Inc.
2007$6.4B$2.5BRepublic Services, Inc.
2006$5.5B$2.1BRepublic Services, Inc.
2005$5.0B$1.6BRepublic Services, Inc.
2004$4.4B$941.1MRepublic Services, Inc.
2003$3.3B$1.5BRepublic Services, Inc.
2002$2.7B$1.9BRepublic Services, Inc.
2001$2.6B$2.9BRegeneron Pharmaceuticals, Inc.
2000$2.2B$3.6BRegeneron Pharmaceuticals, Inc.
1999$1.8B$1.3BRepublic Services, Inc.
1998$2.4B$753.6MRepublic Services, Inc.